Day: May 26, 2020

Baltika Grupp lõpetas esimese kvartali 2 474 tuhande euro suuruse puhaskahjumiga. Eelmise aasta sama perioodi kahjum oli 1 442 tuhat eurot. Esimese kvartali negatiivne majandustulemus on tugevalt mõjutatud nõrgast märtsikuust, mida põhjustas ülemaailmne COVID-19 pandeemia välja kuulutamine. Jaanuari- ja veebruarikuu majandustulemused vastasid ettevõtte prognoosidele.Kõige teravamalt avaldas COVID-19 esimeses kvartalis mõju Baltika Grupi tegevusele Leedus, kus tulenevalt Leedu valitsuse korraldustest suleti alates 16. märtsist kõik kauplused, 27. märtsist suleti valitsuse otsusega kõik kaubanduskeskused Eestis. Lätis olid kauplused avatud lühendatud tööajaga nädala sees ja suletud nädalavahetusel. Alates eriolukorra välja kuulutamisest suunab Baltika Grupp senisest veelgi suuremat ressursi e-poele www.andmorefashion.com, mille kaudu saavad...

SOUTH SAN FRANCISCO, Calif., May 26, 2020 (GLOBE NEWSWIRE) — Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company focused on developing treatments for immune-mediated diseases, today announced upcoming presentations at the European Hematology Association (EHA) and the International Society on Thrombosis and Haemostasis (ISTH) congresses from Principia’s clinical program evaluating rilzabrutinib in patients with immune thrombocytopenia (ITP), a rare autoimmune disease that causes high risk for bleeding, excessive bruising, fatigue and potential for life threatening intracranial bleeding due to destruction of platelets.David Kuter, M.D., Director of Clinical Hematology at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School, will present updates on efficacy and safety, including...

CHANDLER, Ariz., May 26, 2020 (GLOBE NEWSWIRE) — Microchip Technology Incorporated (NASDAQ: MCHP) (“Microchip,” “we” or “our”) announced today that it has commenced offerings of $1.0 billion in aggregate principal amount of senior secured notes (the “Senior Secured Notes”) and $1.2 billion in aggregate principal amount of senior notes (the “Senior Notes” and, together with the Senior Secured Notes, the “Notes”). Microchip intends to use the net proceeds from offering of the Senior Secured Notes to repay in full all amounts outstanding under its senior secured bridge loan facility and to use the remainder of such net proceeds, together with the net proceeds from the offering of Senior Notes and cash on hand, to finance the cash portion of the consideration it will deliver in connection with exchanges of its outstanding 1.625% Convertible...

RESTON, Va., May 26, 2020 (GLOBE NEWSWIRE) — Lightbridge Corporation (NASDAQ: LTBR), an advanced nuclear fuel technology company, today announced that it has received a patent from the Australian Patent Office for its innovative nuclear fuel assemblies. This is a divisional patent of the 2014 PCT application and covers an alternative embodiment for an all-metal fuel assembly design incorporating Lightbridge-designed four-lobe helically twisted fuel rods for use in pressurized water reactors. Lightbridge is developing its advanced metallic fuel designed to make both existing and new nuclear power plants more efficient, more cost competitive, and even safer.Seth Grae, President & Chief Executive Officer of Lightbridge Corporation, said: “Receiving this Australian patent is another important step forward in the development of...

BOULDER, Colo., May 26, 2020 (GLOBE NEWSWIRE) — miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that William S. Marshall, Ph.D., President and Chief Executive Officer of miRagen, will present at the Jefferies Virtual Global Healthcare Conference on Tuesday, June 2, 2020 at 4:00 p.m. ET.The webcast can be accessed at http://wsw.com/webcast/jeff126/mgen/. A live webcast of the event will also be available on the investors page of miRagen’s web site at http://investors.miragen.com/events/. Following the live webcast, a replay will be available on miRagen’s website.About miRagen TherapeuticsmiRagen Therapeutics, Inc. is a clinical-stage biopharmaceutical company discovering and developing proprietary RNA-targeted...

DALLAS and FORT WORTH, Texas, May 26, 2020 (GLOBE NEWSWIRE) — Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that Jerry McLaughlin, President and Chief Executive Officer, will present a company overview at the upcoming Jefferies Virtual Global Healthcare Conference on Tuesday, June 2, 2020, at 9:00 a.m. ET.A live webcast of the presentation will be available on the Investor Relations page of the company’s website at http://investors.neostx.com/. Following the presentation, a replay of the webcast will be available on Neos’ website for 30 days. About Neos TherapeuticsNeos Therapeutics, Inc. (NASDAQ: NEOS) is a commercial-stage pharmaceutical company developing and manufacturing central nervous system (CNS)-focused...

Weekly format of the entertainment series wraps up after mobilizing 70 million viewers to support small businesses200+ More Small Businesses to Receive COVID-19 Relief GrantsNEW YORK, May 26, 2020 (GLOBE NEWSWIRE) — Dave Matthews will return to Pay It Forward Live, Verizon’s weekly live streamed entertainment series in support of small businesses affected by COVID-19 for a second live performance on Thursday, May 28 at 8:00 p.m. ET / 5:00 p.m. PT. Matthews kicked off the series on March 26 from his home in Seattle, where he will perform again for the final installment of the weekly version of the series. Details about how Pay It Forward Live will evolve this summer, as Verizon continues to support and provide resources for the small business community, will be announced soon.  “It’s very important to try and find ways to look...

BOSTON, May 26, 2020 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President and Chief Executive Officer, will present via webcast at the 2020 Jefferies Virtual Healthcare Conference on Tuesday, June 2, at 8:30 a.m. EDT.The live webcast of the presentation will be accessible from the Media & Investors page of Albireo’s website, ir.albireopharma.com. To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes prior to the scheduled start time. An archived version of the webcast will be available for replay in the Events & Presentations section of the Media & Investors page of Albireo’s website for at least two weeks following the event.About...

SAN JOSE, Calif., May 26, 2020 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today that another new US patent titled “Apparatus for Improved Disease Detection” was granted to the Company by the United States Patent and Trademark Office on May 20, 2020, which is the second AnPac Bio patent granted this month, and the third in 2020. The new patent covers novel medical device structures, methods, and biophysical related test parameters for improved detection performance. The newly granted patent this week brings the total number of issued and granted AnPac Bio patents to nineteen in the United States.“AnPac Bio has always focused on technological...